Before you sell to, join or invest in Rgenta Therapeutics, Inc.
MentionFox check on Rgenta Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/rgenta-therapeutics-inc-form-d-001529
Check Rgenta Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Rgenta Therapeutics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Rgenta Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-03.
Rgenta Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 3, 2026. The filing reports $41.85M sold. Its industry group is Other Technology. It names Hualin Xi (Executive Officer, Director), Yichao Fan (Director), Debasish Roychowdhury (Director) (SEC Form D, November 3, 2026).
Selling to Rgenta Therapeutics, Inc.? See who runs it and how to reach them, plus this week's 43 other newly funded companies.
Is this your company?
Sell to companies like Rgenta Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-11-03 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Rgenta Therapeutics, Inc.
Free to see. No signup.
Get an email when Rgenta Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Rgenta Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Rgenta Therapeutics, Inc. →Get the full cited report on Rgenta Therapeutics, Inc.
What the filing shows about Rgenta Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Rgenta Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Rgenta Therapeutics, Inc.'s address as 300 TradeCenter, Suite 6600, Woburn, MA 01801.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Rgenta Therapeutics, Inc. See pricing
Rgenta Therapeutics, Inc. is a registered filer with the SEC (CIK 1801266) and has filed since 2026-11-03. 1 filing is on record, the latest on 2026-11-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Rgenta Therapeutics, Inc.'s Form D of 2026-11-03 names Hualin Xi, Yichao Fan, Debasish Roychowdhury and 7 more as its officers, directors or promoters.
Its new offerings report $41.85M sold across 1 offering, as its own filings state.
Trailing twelve months. 3855 filings in Other Technology, totalled by week. The dot is this raise, $41.85M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Hualin Xi is named as Executive Officer and Director on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
Yichao Fan is named as Director on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
Debasish Roychowdhury is named as Director on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
Julia Kaufman is named as Director on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
Sean Zhang is named as Director and Promoter on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
Cillian King is named as Director and Promoter on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
James Kasuboski is named as Director on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
Travis Wager is named as Executive Officer on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
Weng Zhiping is named as Director on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
Jeff Guckert is named as Executive Officer on the Form D that Rgenta Therapeutics, Inc. filed with the SEC on 3 November 2026, one of 10 people that filing names.
10 people named on the filing — 3 holding an executive role and 7 as directors only.
Named as of the 2026-11-03 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Rgenta Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Rgenta Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Rgenta Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Rgenta Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Rgenta Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Rgenta Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises, week of 2026-11-02 · AI and software raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/rgenta-therapeutics-inc-form-d-001529